Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology
Oricell Therapeutics, an innovative pharmaceutical company committed to the development of clinical-stage oncology cell therapies, […]
ClariMed Launches Integrated Medical Device Services Partner
ClariMed has announced the launch of the first MedTech services partner to take an integrated, […]
Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev
Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]
Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors
Vesigen Therapeutics, a biotechnology company developing transformative therapeutics by engineering naturally existing vesicles, today announced […]
Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer
Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced […]
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease
Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Eosinophilic Esophagitis
Regeneron Pharmaceuticals and Sanofi today announced that the European Commission (EC) expanded the marketing authorization […]
Alpha Biopharma Submits New Drug Application for NSCLC Patients with CNS Metastases
Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) […]
BioArctic: Lecanemab Receives Priority Review Status in Japan
BioArctic AB’s partner Eisai has announced that the application for manufacturing and marketing approval for […]
MGI Makes its Mark in Dubai with Latest Platforms at MEDLAB Middle East and Arab Health
MGI Tech, a company committed to building core tools and technology to lead life science, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more